Cargando…

Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence

Detalles Bibliográficos
Autores principales:	Gao, Yong-Hua, Chen, Rong-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8280091/ https://www.ncbi.nlm.nih.gov/pubmed/34250958 http://dx.doi.org/10.1097/CM9.0000000000001340

Ejemplares similares

Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: López-Campos, José Luis, et al.
Publicado: (2021)

Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?
por: Vestbo, Jørgen
Publicado: (2020)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease
por: Feng, Han-Rong, et al.
Publicado: (2018)

Reply to López-Campos et al.: Triple-Therapy Trials for Chronic Obstructive Pulmonary Disease: Methodological Considerations in the Mortality Effect
por: Lipson, David A., et al.
Publicado: (2021)

Chronic obstructive pulmonary disease in primary healthcare institutions in China: Challenges and solutions()
por: Sun, Yong-Chang
Publicado: (2020)

Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: Implications and Future Research
por: Chen, Ya-Hong, et al.
Publicado: (2016)

Lipids in Chronic Obstructive Pulmonary Disease: A Target for Future Therapy?
por: Vlahos, Ross
Publicado: (2020)

Is One Exacerbation Enough to Modify Therapy in Chronic Obstructive Pulmonary Disease?
por: Mannino, David M.
Publicado: (2023)

Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Considerations for managing chronic obstructive pulmonary disease in the elderly
por: Taffet, George E, et al.
Publicado: (2013)

More attention to comprehensive assessment and individualized therapy of chronic obstructive pulmonary disease
por: Hou, Gang, et al.
Publicado: (2015)

A New Treatment for Chronic Obstructive Pulmonary Disease: Ensifentrine Moves Closer
por: Singh, Dave
Publicado: (2023)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

The Complex Beginnings of Chronic Obstructive Pulmonary Disease
por: Guerra, Stefano, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease: The Present and Future
por: Krishnan, Aditya, et al.
Publicado: (2022)

Addressing the Use of the CAPTURE (a Chronic Obstructive Pulmonary Disease Screening Tool) in Chronic Obstructive Pulmonary Disease Treatment Decisions
por: Yawn, Barbara P., et al.
Publicado: (2023)

Transcriptome-based Signatures: The Future Biomarkers in Obstructive Pulmonary Diseases Such as Asthma and Chronic Obstructive Pulmonary Disease?
por: van den Berge, Maarten, et al.
Publicado: (2021)

Patient and Clinical Demographics of New Users to Single-Inhaler Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease
por: Wu, Benjamin, et al.
Publicado: (2022)

Interpretation of the Key Issues of Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease
por: Sun, Lina, et al.
Publicado: (2023)

Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis
por: Zheng, Yayuan, et al.
Publicado: (2018)

Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States
por: Schabert, Vernon, et al.
Publicado: (2021)

Innate Immune Reprogramming in Chronic Obstructive Pulmonary Disease: New Mechanisms for Old Questions
por: Kim, Richard Y., et al.
Publicado: (2023)

Reducing chronic obstructive pulmonary disease mortality in Korea: early diagnosis matters
por: Hwang, Yong Il
Publicado: (2019)

What Affects Chronic Obstructive Pulmonary Disease in Korea?
por: Cho, Hae-Wol, et al.
Publicado: (2016)

High prevalence of chronic obstructive pulmonary disease in Korea
por: Rhee, Chin Kook
Publicado: (2016)

Drugging the Mighty Neutrophil in Chronic Obstructive Pulmonary Disease
por: Fessler, Michael B.
Publicado: (2019)

Validation of Imaging Measures in Chronic Obstructive Pulmonary Disease
por: Aaron, Carrie Pistenmaa, et al.
Publicado: (2019)

Chronic Obstructive Pulmonary Disease and Work: Is It Time to Stop?
por: Halpin, David
Publicado: (2019)

Genetics, Chronic Obstructive Pulmonary Disease, and the Arrow of Time
por: Calverley, Peter M. A., et al.
Publicado: (2019)

The Saga of Necroptosis in Chronic Obstructive Pulmonary Disease Continues
por: Racanelli, Alexandra C., et al.
Publicado: (2021)

The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease
por: Yohannes, Abebaw Mengistu
Publicado: (2022)

The role of quantitative imaging in chronic obstructive pulmonary disease
por: Wada, Danilo Tadao
Publicado: (2022)

The triple therapy for chronic obstructive pulmonary disease increases the risk of pneumonias compared to the dual-bronchodilator therapy
por: Watanabe, Keisuke, et al.
Publicado: (2021)

Pulse Oximetry Misclassifies Need for Long-Term Oxygen Therapy in Chronic Obstructive Pulmonary Disease
por: Fawzy, Ashraf, et al.
Publicado: (2023)

A STAR Is Born: A New Approach to Assessing Chronic Obstructive Pulmonary Disease Severity
por: Calverley, Peter M. A.
Publicado: (2023)

Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
por: Langham, Sue, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a1dhgol9c2ou0bltqnvlpds3qm